Evidence map›Paper›PMID 37696982›Full record

ArticleGene therapy2024

Acoustically targeted noninvasive gene therapy in large brain volumes.

Shirin Nouraein, Sangsin Lee, Vidal A Saenz, Huckie C Del Mundo, Joycelyn Yiu, Jerzy O Szablowski

Abstract read
PubMed Publisher
In one paragraph

Article in Gene therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Tissue-specific gene delivery approaches.Bioengineering & translational medicine · 2026
    Review
  3. Article
  4. Review
  5. Erasable serum markers.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Shirin NouraeinDepartment of Bioengineering, Rice University, Houston, TX, 77030, USA.ORCID 0000-0003-3423-1002
Sangsin LeeDepartment of Bioengineering, Rice University, Houston, TX, 77030, USA.ORCID 0000-0002-1306-2206
Vidal A SaenzDepartment of Bioengineering, Rice University, Houston, TX, 77030, USA.
Huckie C Del MundoDepartment of Bioengineering, Rice University, Houston, TX, 77030, USA.
Joycelyn YiuDepartment of Bioengineering, Rice University, Houston, TX, 77030, USA.
Jerzy O SzablowskiDepartment of Bioengineering, Rice University, Houston, TX, 77030, USA. jszab@rice.edu.ORCID 0000-0001-7851-5408
Rice University · US

Funding

Welch Foundation C-2048-20200401
6 · The paper itself

Abstract

Focused Ultrasound Blood-Brain Barrier Opening (FUS-BBBO) can deliver adeno-associated viral vectors (AAVs) to treat genetic disorders of the brain. However, such disorders often affect large brain regions. Moreover, the applicability of FUS-BBBO in the treatment of brain-wide genetic disorders has not yet been evaluated. Herein, we evaluated the transduction efficiency and safety of opening up to 105 sites simultaneously. Increasing the number of targeted sites increased gene delivery efficiency at each site. We achieved transduction of up to 60% of brain cells with comparable efficiency in the majority of the brain regions. Furthermore, gene delivery with FUS-BBBO was safe even when all 105 sites were targeted simultaneously without negative effects on animal weight or neuronal loss. To evaluate the application of multi-site FUS-BBBO for gene therapy, we used it for gene editing using the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 (Cas9) system and found effective gene editing, but also a loss of neurons at the targeted sites. Overall, this study provides a brain-wide map of transduction efficiency, shows the synergistic effect of multi-site targeting on transduction efficiency, and is the first example of large brain volume gene editing after noninvasive gene delivery with FUS-BBBO.

Indexed as

Gene EditingGenetic TherapyAnimalsBlood-Brain BarrierBrainCRISPR-Cas SystemsGene Transfer Techniques

Identifiers

PMID37696982
OpenAlexW4386624504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.